| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | medium-chain fatty acid omega-hydroxylase activity | 7.64e-05 | 2 | 175 | 2 | GO:0140981 | |
| GeneOntologyMolecularFunction | 16-hydroxypalmitate dehydrogenase activity | 7.64e-05 | 2 | 175 | 2 | GO:0103002 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | TRIT1 NTHL1 DCP2 CARS1 UPF1 TRUB1 ARID1A ERN2 ZRANB3 EXD2 SMARCA2 SMARCA4 DDX3Y PRORP VARS1 TOP2B | 1.83e-04 | 645 | 175 | 16 | GO:0140640 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.00e-04 | 37 | 175 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | CENPE RNF213 UPF1 ARID1A ZRANB3 DNAH1 MDN1 AFG3L2 SMARCA2 SMARCA4 MACF1 DDX3Y DNAH8 TOP2B KIF22 | 3.44e-04 | 614 | 175 | 15 | GO:0140657 |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 1.66e-05 | 95 | 175 | 7 | GO:2000781 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | KAT5 CENPE DCP2 UPF1 SIRT6 ARID1A WDHD1 HECW2 BUB1 SMARCA2 SMARCA4 | 1.77e-05 | 266 | 175 | 11 | GO:0033044 |
| GeneOntologyBiologicalProcess | chromosome organization | KAT5 CENPE DCP2 NASP UPF1 SIRT6 ARID1A ERN2 ZRANB3 WDHD1 RRS1 HECW2 BUB1 SMARCA2 SMARCA4 PRKDC TOP2B KIF22 | 2.28e-05 | 686 | 175 | 18 | GO:0051276 |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 3.57e-05 | 146 | 175 | 8 | GO:2000779 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 4.54e-05 | 111 | 175 | 7 | GO:0033045 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | KAT5 CENPE PTEN ARID1A WASHC5 RRS1 HECW2 BUB1 SMARCA2 SMARCA4 TOP2B KIF22 | 5.49e-05 | 356 | 175 | 12 | GO:0098813 |
| GeneOntologyBiologicalProcess | sister chromatid segregation | KAT5 CENPE ARID1A RRS1 HECW2 BUB1 SMARCA2 SMARCA4 TOP2B KIF22 | 6.49e-05 | 254 | 175 | 10 | GO:0000819 |
| GeneOntologyBiologicalProcess | phosphatidylinositol dephosphorylation | 1.15e-04 | 30 | 175 | 4 | GO:0046856 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular senescence | 1.15e-04 | 30 | 175 | 4 | GO:2000773 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound metabolic process | 1.34e-04 | 92 | 175 | 6 | GO:0072527 | |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 1.37e-04 | 278 | 175 | 10 | GO:0031503 | |
| GeneOntologyBiologicalProcess | regulation of receptor internalization | 1.59e-04 | 95 | 175 | 6 | GO:0002090 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 1.59e-04 | 95 | 175 | 6 | GO:0030071 | |
| GeneOntologyBiologicalProcess | chromosome segregation | KAT5 CENPE NR3C1 PTEN ARID1A WASHC5 RRS1 HECW2 BUB1 SMARCA2 SMARCA4 TOP2B KIF22 | 1.76e-04 | 465 | 175 | 13 | GO:0007059 |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 1.87e-04 | 139 | 175 | 7 | GO:0051983 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 1.89e-04 | 98 | 175 | 6 | GO:1902099 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 2.11e-04 | 100 | 175 | 6 | GO:0007091 | |
| GeneOntologyBiologicalProcess | lauric acid metabolic process | 2.14e-04 | 3 | 175 | 2 | GO:0048252 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 2.23e-04 | 143 | 175 | 7 | GO:0045739 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 2.27e-04 | 65 | 175 | 5 | GO:0045815 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 2.31e-04 | 242 | 175 | 9 | GO:1903708 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 2.31e-04 | 242 | 175 | 9 | GO:1902107 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 2.48e-04 | 103 | 175 | 6 | GO:0044784 | |
| GeneOntologyBiologicalProcess | organelle assembly | CENPE SYNE1 SPEF2 SPTBN2 TBC1D2B RNF213 CASQ1 TOGARAM1 PTEN IFT43 DNAH1 MDN1 RAB34 WASHC5 RRS1 PRKDC HSF1 DNAH8 AP3D1 MYBPC1 PCNT MYBPC3 | 2.63e-04 | 1138 | 175 | 22 | GO:0070925 |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 2.81e-04 | 68 | 175 | 5 | GO:0141137 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor internalization | 3.27e-04 | 39 | 175 | 4 | GO:0099149 | |
| GeneOntologyCellularComponent | bBAF complex | 6.74e-05 | 10 | 176 | 3 | GO:0140092 | |
| GeneOntologyCellularComponent | npBAF complex | 1.99e-04 | 14 | 176 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | chromosomal region | KAT5 NLRP7 CENPE UPF1 SIRT6 WDHD1 TELO2 BUB1 SMARCA4 PRKDC HSF1 KIF22 | 2.46e-04 | 421 | 176 | 12 | GO:0098687 |
| GeneOntologyCellularComponent | nBAF complex | 3.03e-04 | 16 | 176 | 3 | GO:0071565 | |
| Domain | SPEC | 4.60e-07 | 32 | 175 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 4.60e-07 | 32 | 175 | 6 | IPR018159 | |
| Domain | Spectrin_repeat | 6.75e-06 | 29 | 175 | 5 | IPR002017 | |
| Domain | Spectrin | 5.74e-05 | 23 | 175 | 4 | PF00435 | |
| Domain | Gln-Leu-Gln_QLQ | 8.73e-05 | 2 | 175 | 2 | IPR014978 | |
| Domain | SnAC | 8.73e-05 | 2 | 175 | 2 | PF14619 | |
| Domain | QLQ | 8.73e-05 | 2 | 175 | 2 | SM00951 | |
| Domain | QLQ | 8.73e-05 | 2 | 175 | 2 | PS51666 | |
| Domain | SnAC | 8.73e-05 | 2 | 175 | 2 | SM01314 | |
| Domain | MAGEA3/MAGEA6 | 8.73e-05 | 2 | 175 | 2 | IPR030097 | |
| Domain | SnAC | 8.73e-05 | 2 | 175 | 2 | IPR029295 | |
| Domain | QLQ | 8.73e-05 | 2 | 175 | 2 | PF08880 | |
| Domain | ARM-type_fold | INTS1 TOGARAM1 ECPAS ARID1A NCDN RYR3 PIK3C2A TELO2 RPTOR PRKDC BRAT1 AP3D1 | 8.77e-05 | 339 | 175 | 12 | IPR016024 |
| Domain | HEAT | 2.09e-04 | 58 | 175 | 5 | IPR000357 | |
| Domain | P4Ha_N | 2.60e-04 | 3 | 175 | 2 | PF08336 | |
| Domain | Pro_4_hyd_alph_N | 2.60e-04 | 3 | 175 | 2 | IPR013547 | |
| Domain | ATPase_dyneun-rel_AAA | 2.73e-04 | 14 | 175 | 3 | IPR011704 | |
| Domain | AAA_5 | 2.73e-04 | 14 | 175 | 3 | PF07728 | |
| Domain | HEAT_REPEAT | 5.05e-04 | 70 | 175 | 5 | PS50077 | |
| Domain | HSA | 5.17e-04 | 4 | 175 | 2 | SM00573 | |
| Domain | HSA | 5.17e-04 | 4 | 175 | 2 | PS51204 | |
| Domain | HSA_dom | 5.17e-04 | 4 | 175 | 2 | IPR014012 | |
| Domain | HSA | 5.17e-04 | 4 | 175 | 2 | PF07529 | |
| Domain | MAGE_N | 8.20e-04 | 20 | 175 | 3 | SM01392 | |
| Domain | ER_TARGET | 9.70e-04 | 47 | 175 | 4 | PS00014 | |
| Domain | HEAT | 1.05e-03 | 48 | 175 | 4 | PF02985 | |
| Domain | MAGE_N | 1.09e-03 | 22 | 175 | 3 | PF12440 | |
| Domain | MAGE_N | 1.09e-03 | 22 | 175 | 3 | IPR021072 | |
| Domain | - | 1.19e-03 | 222 | 175 | 8 | 1.25.10.10 | |
| Domain | ACTININ_2 | 1.25e-03 | 23 | 175 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.25e-03 | 23 | 175 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.25e-03 | 23 | 175 | 3 | IPR001589 | |
| Domain | BRK | 1.28e-03 | 6 | 175 | 2 | SM00592 | |
| Domain | - | 1.28e-03 | 6 | 175 | 2 | 3.90.1290.10 | |
| Domain | BRK_domain | 1.28e-03 | 6 | 175 | 2 | IPR006576 | |
| Domain | Hydantoinase/dihydroPyrase | 1.28e-03 | 6 | 175 | 2 | IPR011778 | |
| Domain | BRK | 1.28e-03 | 6 | 175 | 2 | PF07533 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 DPYSL2 NPEPPS U2SURP UPF1 ARID1A USP16 WDR74 EEF1D PDIA6 FASN ZC3H11A ARHGEF40 MDN1 RAB34 GRHPR PIK3C2A WASHC5 RRS1 RPTOR AFG3L2 SMARCA2 SMARCA4 FIP1L1 MACF1 PRKDC MRPL49 AP3D1 VARS1 TOP2B | 1.75e-11 | 1353 | 180 | 30 | 29467282 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NPEPPS SYNE1 U2SURP SPTBN2 INTS1 NCDN EEF1D PDIA6 FASN ZC3H11A MDN1 PTPRF PRPF4 RRS1 EXD2 AFG3L2 SMARCA4 FIP1L1 MACF1 PRKDC VARS1 TOP2B KIF22 PCNT | 7.65e-10 | 1024 | 180 | 24 | 24711643 |
| Pubmed | STRN3 DPYSL2 RNF213 TNS2 UPF1 ECPAS WDR26 EEF1D WASHC5 AFG3L2 SMARCA2 SMARCA4 CRBN MYBPC3 | 7.87e-10 | 304 | 180 | 14 | 32235678 | |
| Pubmed | AKAP6 DPYSL2 CLSTN3 SYNE1 SPTBN2 NUCB1 NASP ARID1A USP16 WDR26 PREPL MTMR10 RYR3 SYNJ1 GRHPR USP32 SMARCA4 FIP1L1 MACF1 LRPAP1 RNF216 PRKDC VARS1 SEZ6L PCNT | 1.38e-08 | 1285 | 180 | 25 | 35914814 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | STRN3 DPYSL2 DPYSL3 U2SURP CCDC85C NASP UPF1 NR3C1 USP16 PDIA6 FASN ZC3H11A SYNJ1 RRS1 AFG3L2 SMARCA4 MACF1 PRKDC AP3D1 TOP2B PCNT | 1.95e-08 | 934 | 180 | 21 | 33916271 |
| Pubmed | STRN3 DPYSL2 DPYSL3 NPEPPS SYNE1 SPTBN2 UPF1 ARID1A NCDN NDUFV1 EEF1D PDIA6 FASN SYNJ1 WASHC5 HECW2 RPTOR AFG3L2 SCAPER SMARCA4 MACF1 DDX3Y PLCL1 AP3D1 VARS1 CNTN2 | 2.73e-08 | 1431 | 180 | 26 | 37142655 | |
| Pubmed | DPYSL2 DPYSL3 NPEPPS CARS1 MAGOHB NASP NR3C1 TRUB1 ECPAS NDUFV1 EEF1D PDIA6 FASN GRHPR PRPF4 FDXR DDX3Y PRKDC BRAT1 VARS1 | 3.52e-08 | 878 | 180 | 20 | 37223481 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | STRN3 CENPE SYNE1 U2SURP DCP2 CCDC85C CPS1 ARID1A NCDN FBXO38 EDEM3 PDIA6 FASN PRPF4 WASHC5 BUB1 SMARCA2 SMARCA4 CCDC97 PRKDC HSF1 CRBN TOP2B | 3.65e-08 | 1155 | 180 | 23 | 20360068 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CENPE NPEPPS U2SURP SPTBN2 TBC1D2B NASP ECPAS RYR3 WDR74 MDN1 RRS1 ZNF408 AFG3L2 USP32 AP3D1 | 5.64e-08 | 497 | 180 | 15 | 36774506 |
| Pubmed | SYNE1 SPTBN2 NUCB1 UPF1 CNPY2 NR3C1 USP16 PREPL NCDN NDUFV1 WDR74 PLEKHG1 LIFR PDIA6 MDN1 PIK3C2A TELO2 RRS1 AFG3L2 MACF1 LRPAP1 CCDC97 MRPL49 AP3D1 TOP2B PCNT | 5.84e-08 | 1487 | 180 | 26 | 33957083 | |
| Pubmed | DPYSL2 NPEPPS U2SURP SPTBN2 INTS1 UPF1 ECPAS ARID1A FASN ZC3H11A MDN1 RRS1 SMARCA2 SMARCA4 MACF1 PRKDC PCNT | 6.04e-08 | 653 | 180 | 17 | 22586326 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | P4HA2 MAGEA12 PODXL INTS1 CCDC85C ZNF317 ITGB5 ZFP37 WDR74 EEF1D PDIA6 FASN RAB34 PTPRF WASHC5 RPTOR AFG3L2 LRPAP1 RNF216 PRKDC BRAT1 AP3D1 TOP2B | 7.59e-08 | 1203 | 180 | 23 | 29180619 |
| Pubmed | DPYSL2 KAT5 INTS1 RNF213 UPF1 SIRT6 ECPAS WDR26 EEF1D FASN ZC3H11A MDN1 WDHD1 PRPF4 SMARCA2 SMARCA4 FIP1L1 SMS PRKDC BRAT1 TOP2B | 7.82e-08 | 1014 | 180 | 21 | 32416067 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | STRN3 NASP ECPAS USP16 FBXO38 PDIA6 FASN ZC3H11A MDN1 WDHD1 RPTOR BRPF1 SMARCA2 SMARCA4 FIP1L1 PRKDC HSF1 TOP2B | 1.31e-07 | 774 | 180 | 18 | 15302935 |
| Pubmed | 1.36e-07 | 3 | 180 | 3 | 36464671 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | STRN3 DPYSL2 DPYSL3 NPEPPS NUCB1 CARS1 NASP NR3C1 ECPAS WDR26 NCDN EEF1D PDIA6 FASN WDHD1 TELO2 PRPF4 WASHC5 MACF1 SMS PRKDC HSF1 BRAT1 AP3D1 VARS1 | 1.50e-07 | 1455 | 180 | 25 | 22863883 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DPYSL2 KAT5 SYNE1 U2SURP SPTBN2 INTS1 UPF1 ARID1A NDUFV1 PDIA6 PRPF4 RRS1 SMARCA4 FIP1L1 MACF1 DDX3Y PRKDC MRPL49 AP3D1 VARS1 TOP2B | 2.29e-07 | 1082 | 180 | 21 | 38697112 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | U2SURP INTS1 MAGOHB NASP UPF1 USP16 WDR74 EEF1D FASN MDN1 PRPF4 WASHC5 RRS1 AFG3L2 SMARCA2 SMARCA4 DDX3Y PRKDC MRPL49 AP3D1 VARS1 TOP2B KIF22 | 3.79e-07 | 1318 | 180 | 23 | 30463901 |
| Pubmed | CENPE SYNE1 FBXO38 EEF1D MDN1 BRPF1 SMARCA4 MACF1 VARS1 TOP2B | 4.41e-07 | 234 | 180 | 10 | 36243803 | |
| Pubmed | STARD13 STRN3 NLRP7 SYNE1 SPEF2 U2SURP SPTBN2 NUCB1 CNPY2 COQ3 ARID1A EEF1D PDIA6 FASN MDN1 RRS1 MACF1 PRKDC DNAH8 AP3D1 VARS1 TOP2B MYBPC1 PCNT | 4.83e-07 | 1442 | 180 | 24 | 35575683 | |
| Pubmed | 5.43e-07 | 4 | 180 | 3 | 31906887 | ||
| Pubmed | 5.43e-07 | 4 | 180 | 3 | 26055322 | ||
| Pubmed | 5.43e-07 | 4 | 180 | 3 | 33481850 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXN1 KAT5 NR3C1 CPS1 ECPAS NDUFV1 EEF1D FASN ZC3H11A MDN1 WDHD1 SH3TC1 SMARCA4 FIP1L1 VARS1 TOP2B KIF22 TBX2 | 5.75e-07 | 857 | 180 | 18 | 25609649 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | STRN3 DPYSL2 DPYSL3 NPEPPS U2SURP SPTBN2 NASP UPF1 NR3C1 ECPAS WDR26 PREPL EEF1D PDIA6 FASN MDN1 FIP1L1 MACF1 PRKDC AP3D1 VARS1 | 6.06e-07 | 1149 | 180 | 21 | 35446349 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DPYSL2 NPEPPS TNS2 EVPL PTEN ECPAS WDR26 PREPL MTMR10 PDIA6 FASN RAB34 PTPRF TELO2 AFG3L2 SMS PRKDC PRORP VARS1 | 8.30e-07 | 974 | 180 | 19 | 28675297 |
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 9.06e-07 | 15 | 180 | 4 | 17255939 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | UPF1 CPS1 EEF1D FASN WDHD1 GRHPR PRPF4 FDXR SMARCA2 SMARCA4 DDX3Y SMS PRKDC DNAH8 AP3D1 TOP2B | 9.09e-07 | 704 | 180 | 16 | 29955894 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | STARD13 NPEPPS SYNE1 UPF1 ECPAS EPG5 DNAH1 EEF1D PDIA6 FASN MDN1 GRHPR BRPF1 MACF1 SMS PRKDC AP3D1 | 1.16e-06 | 807 | 180 | 17 | 30575818 |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 1.23e-06 | 262 | 180 | 10 | 36880596 | |
| Pubmed | DPYSL2 DPYSL3 PODXL NPEPPS MAGOHB NASP UPF1 EEF1D PDIA6 FASN PRKDC VARS1 | 1.23e-06 | 397 | 180 | 12 | 21319273 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | INTS1 PLXND1 ARID1A ITGB5 C2CD2 PLEKHG1 FASN ZC3H11A ARHGEF40 MDN1 PTPRF SYNJ1 SH3TC1 RRS1 RPTOR ZNF408 PRKDC BRAT1 AP3D1 PCNT | 1.33e-06 | 1105 | 180 | 20 | 35748872 |
| Pubmed | UPF1 ECPAS WDR26 EEF1D PDIA6 FASN MDN1 WDHD1 TELO2 PRPF4 SMARCA4 PRKDC AP3D1 VARS1 TOP2B | 1.33e-06 | 638 | 180 | 15 | 33239621 | |
| Pubmed | Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). | 1.35e-06 | 5 | 180 | 3 | 9843504 | |
| Pubmed | 1.35e-06 | 5 | 180 | 3 | 18086889 | ||
| Pubmed | 1.35e-06 | 5 | 180 | 3 | 8037761 | ||
| Pubmed | 1.35e-06 | 5 | 180 | 3 | 12200431 | ||
| Pubmed | KAT5 RNF213 ARID1A WDR26 EDEM3 ARHGEF40 SH3TC1 TELO2 PRPF4 RPTOR BRPF1 AFG3L2 SCAPER SMARCA2 SMARCA4 FIP1L1 MACF1 CLMP SEZ6L TBX2 | 1.55e-06 | 1116 | 180 | 20 | 31753913 | |
| Pubmed | CLSTN3 AVL9 SYNE1 NCDN EPG5 PLEKHG1 ZC3H11A RRS1 MACF1 TET3 SEZ6L PCNT | 1.59e-06 | 407 | 180 | 12 | 12693553 | |
| Pubmed | TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation. | 2.01e-06 | 18 | 180 | 4 | 28068325 | |
| Pubmed | DPYSL3 KAT5 PODXL SYNE1 NASP P4HA3 UPF1 ECPAS ZFP37 EEF1D FASN RAB34 PTPRF RRS1 SMARCA4 HSF1 | 2.20e-06 | 754 | 180 | 16 | 35906200 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | U2SURP INTS1 UPF1 TRUB1 ARID1A FASN MDN1 BUB1 SMARCA2 SMARCA4 FIP1L1 MACF1 PRKDC PCNT | 2.33e-06 | 582 | 180 | 14 | 20467437 |
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 2.70e-06 | 6 | 180 | 3 | 25081545 | |
| Pubmed | 2.70e-06 | 6 | 180 | 3 | 16940996 | ||
| Pubmed | A nucleolar protein RRS1 contributes to chromosome congression. | 2.70e-06 | 6 | 180 | 3 | 19465021 | |
| Pubmed | 2.70e-06 | 6 | 180 | 3 | 16230384 | ||
| Pubmed | STRN3 DPYSL2 CENPE NPEPPS SYNE1 SPTBN2 UPF1 WDR26 TMEM132B PREPL NCDN MDN1 SYNJ1 RPTOR SMARCA4 MACF1 PLCL1 PCNT | 2.98e-06 | 963 | 180 | 18 | 28671696 | |
| Pubmed | AKAP6 STARD13 DPYSL2 B3GNT5 PODXL GGT6 GSDMB THTPA EVPL CPS1 NDUFV1 LIFR MDN1 SLC22A8 SYNJ1 BUB1 PLCL1 PRORP BRAT1 MYBPC1 PCNT | 3.89e-06 | 1293 | 180 | 21 | 15342556 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 4.13e-06 | 235 | 180 | 9 | 30258100 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | P4HA2 DPYSL2 DPYSL3 CLSTN3 PODXL NUCB1 RNF213 P4HA3 PLXND1 CNPY2 ITGB5 LIFR EDEM3 EEF1D PDIA6 ZC3H11A RAB34 PTPRF SCAPER LRPAP1 | 4.64e-06 | 1201 | 180 | 20 | 35696571 |
| Pubmed | 4.70e-06 | 7 | 180 | 3 | 17043312 | ||
| Pubmed | A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes. | 4.70e-06 | 7 | 180 | 3 | 21079652 | |
| Pubmed | Expression of melanoma-associated antigens in oral squamous cell carcinoma. | 4.70e-06 | 7 | 180 | 3 | 18197853 | |
| Pubmed | NPEPPS INPP5D U2SURP MAGOHB UPF1 ECPAS ARID1A WDR74 EEF1D FASN ZC3H11A PRPF4 SMARCA2 SMARCA4 FIP1L1 SMS PRKDC VARS1 TOP2B | 5.06e-06 | 1103 | 180 | 19 | 34189442 | |
| Pubmed | 7.49e-06 | 8 | 180 | 3 | 26986003 | ||
| Pubmed | MAGE cancer-testis antigens protect the mammalian germline under environmental stress. | 7.49e-06 | 8 | 180 | 3 | 31149633 | |
| Pubmed | The Magea gene cluster regulates male germ cell apoptosis without affecting the fertility in mice. | 7.49e-06 | 8 | 180 | 3 | 27226137 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DPYSL2 CENPE SPTBN2 INTS1 RNF213 EVPL ECPAS TMEM132B FBXO10 MDN1 GRHPR HECW2 ZNF408 PRKDC C6 | 7.49e-06 | 736 | 180 | 15 | 29676528 |
| Pubmed | DPYSL2 INTS1 NASP PDIA6 ZC3H11A FDXR USP32 MACF1 PRKDC VARS1 | 7.67e-06 | 322 | 180 | 10 | 26514267 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | NPEPPS U2SURP INTS1 NASP UPF1 WDR26 EEF1D PDIA6 FASN MDN1 TELO2 RPTOR EXD2 AFG3L2 SMARCA4 FIP1L1 DDX3Y PRKDC BRAT1 VARS1 | 9.06e-06 | 1257 | 180 | 20 | 37317656 |
| Pubmed | U2SURP EVPL UPF1 CPS1 EEF1D FASN ZC3H11A MDN1 PRPF4 WASHC5 RRS1 BRPF1 SMARCA4 FIP1L1 PRKDC TOP2B | 9.51e-06 | 847 | 180 | 16 | 35850772 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | DPYSL2 DPYSL3 U2SURP SPTBN2 CARS1 NASP ARID1A EEF1D MDN1 SCAPER SMARCA2 SMARCA4 MACF1 PRKDC AP3D1 PCNT | 9.51e-06 | 847 | 180 | 16 | 35235311 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | RNF213 UPF1 FBXO38 FASN ZC3H11A MDN1 WDHD1 SMARCA4 PRKDC VARS1 | 1.00e-05 | 332 | 180 | 10 | 32786267 |
| Pubmed | P4HA2 DPYSL2 U2SURP NUCB1 CARS1 CNPY2 NDUFV1 EDEM3 EEF1D PDIA6 FASN ARHGEF40 AFG3L2 MACF1 LRPAP1 PRKDC BRAT1 MRPL49 AP3D1 KIF22 | 1.42e-05 | 1297 | 180 | 20 | 33545068 | |
| Pubmed | DPYSL3 U2SURP NASP ARID1A PDIA6 FASN WDHD1 SYNJ1 PRPF4 WASHC5 SMARCA4 CCDC97 | 1.44e-05 | 506 | 180 | 12 | 30890647 | |
| Pubmed | 1.49e-05 | 29 | 180 | 4 | 36800290 | ||
| Pubmed | 1.52e-05 | 152 | 180 | 7 | 34299191 | ||
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 1.59e-05 | 10 | 180 | 3 | 23129809 | |
| Pubmed | 1.59e-05 | 10 | 180 | 3 | 11839798 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | U2SURP NASP WDR74 EEF1D PDIA6 FASN ZC3H11A MDN1 RRS1 FDXR SMARCA4 FIP1L1 PRKDC BRAT1 VARS1 TOP2B KIF22 | 1.67e-05 | 989 | 180 | 17 | 36424410 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NPEPPS SYNE1 U2SURP CARS1 NASP UPF1 ECPAS NDUFV1 EEF1D PDIA6 FASN ZC3H11A MDN1 PRPF4 RRS1 RPTOR SMARCA4 PRKDC VARS1 TOP2B MYBPC1 | 1.69e-05 | 1425 | 180 | 21 | 30948266 |
| Pubmed | 1.76e-05 | 215 | 180 | 8 | 35973513 | ||
| Pubmed | 1.76e-05 | 104 | 180 | 6 | 9205841 | ||
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 1.83e-05 | 283 | 180 | 9 | 28533407 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 2.18e-05 | 11 | 180 | 3 | 20427287 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | STARD13 DPYSL2 U2SURP NUCB1 INTS1 RNF213 CNPY2 COQ3 ARID1A ITGB5 NFU1 NDUFV1 PDIA6 FASN RAB34 FDXR SMARCA4 FIP1L1 LRPAP1 AP3D1 VARS1 | 2.20e-05 | 1451 | 180 | 21 | 30550785 |
| Pubmed | DPYSL2 NPEPPS UPF1 ECPAS NDUFV1 EEF1D PDIA6 FASN PRPF4 FDXR FIP1L1 MACF1 PRKDC VARS1 | 2.22e-05 | 711 | 180 | 14 | 33022573 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | SYNE1 U2SURP MAGOHB UPF1 EEF1D PDIA6 FASN ZC3H11A PRPF4 RRS1 PRKDC AP3D1 VARS1 TOP2B | 2.33e-05 | 714 | 180 | 14 | 28302793 |
| Pubmed | Chromatin remodeling during glucocorticoid receptor regulated transactivation. | 2.66e-05 | 2 | 180 | 2 | 22425674 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 15611369 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 12628722 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 23163725 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 31744878 | ||
| Pubmed | Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. | 2.66e-05 | 2 | 180 | 2 | 21874051 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 15576411 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 30056111 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 21646426 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 2.66e-05 | 2 | 180 | 2 | 33027072 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 8223438 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 25195947 | ||
| Pubmed | Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. | 2.66e-05 | 2 | 180 | 2 | 23641057 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 20333683 | ||
| Pubmed | How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. | 2.66e-05 | 2 | 180 | 2 | 7889411 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 24413902 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 8402693 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 8294461 | ||
| Pubmed | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. | 2.66e-05 | 2 | 180 | 2 | 29391527 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 32019603 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 37634210 | ||
| Pubmed | Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. | 2.66e-05 | 2 | 180 | 2 | 11320253 | |
| Interaction | HNRNPCL2 interactions | TRIT1 U2SURP TBC1D2B NR3C1 FASN ZC3H11A ARHGEF40 SLC22A8 PIK3C2A RRS1 BRAT1 KIF22 | 4.86e-06 | 274 | 174 | 12 | int:HNRNPCL2 |
| Interaction | PBRM1 interactions | CENPE CARS1 SIRT6 NR3C1 PTEN ARID1A MTMR10 FASN HECW2 SMARCA2 SMARCA4 | 1.57e-05 | 258 | 174 | 11 | int:PBRM1 |
| Interaction | TRRAP interactions | KAT5 PODXL SYNE1 DCP2 NASP P4HA3 UPF1 SIRT6 ECPAS ZFP37 STAT2 FBXO38 FASN RAB34 PTPRF TELO2 RRS1 SMARCA4 HSF1 TBX2 | 1.68e-05 | 790 | 174 | 20 | int:TRRAP |
| Interaction | SMARCB1 interactions | FOXN1 SPTBN2 NR3C1 PTEN ARID1A ZC3H11A GADD45G WDHD1 SMARCA2 SMARCA4 HSF1 TOP2B KIF22 | 1.75e-05 | 364 | 174 | 13 | int:SMARCB1 |
| Interaction | PML interactions | KAT5 RNF213 UPF1 SIRT6 NR3C1 STAT2 EEF1D FASN ZC3H11A MDN1 PTPRF PRPF4 RRS1 EXD2 SMARCA4 FIP1L1 RNF216 HSF1 BRAT1 AP3D1 TOP2B TBX2 | 1.86e-05 | 933 | 174 | 22 | int:PML |
| Interaction | FBXO22 interactions | CENPE NPEPPS U2SURP SPTBN2 TBC1D2B NASP PTEN ECPAS RYR3 WDR74 MDN1 RRS1 ZNF408 AFG3L2 USP32 AP3D1 | 1.90e-05 | 540 | 174 | 16 | int:FBXO22 |
| Interaction | BRCA1 interactions | KAT5 NPEPPS CARS1 TNS2 UPF1 ECPAS ARID1A ITIH5 FBXO38 EEF1D FASN ZC3H11A MDN1 RAB34 WDHD1 RPTOR EXD2 SMARCA2 SMARCA4 RNF216 PRKDC BRAT1 VARS1 CRBN TOP2B KIF22 | 2.68e-05 | 1249 | 174 | 26 | int:BRCA1 |
| Interaction | P2RY10 interactions | 3.77e-05 | 106 | 174 | 7 | int:P2RY10 | |
| Interaction | RUVBL1 interactions | DPYSL2 KAT5 UPF1 SIRT6 ARID1A NCDN PLEKHG1 FBXO10 TELO2 PRPF4 RPTOR SMARCA2 PRKDC HSF1 VARS1 CRBN | 4.06e-05 | 575 | 174 | 16 | int:RUVBL1 |
| Interaction | ZNF687 interactions | 6.35e-05 | 115 | 174 | 7 | int:ZNF687 | |
| Interaction | TRIM28 interactions | MAGEA3 MAGEA6 ZNF527 REXO5 KAT5 UPF1 CNPY2 SIRT6 NR3C1 CPS1 ZNF317 PTEN WDR26 EEF1D FASN WDHD1 GRHPR PIK3C2A PRPF4 FDXR SMARCA2 SMARCA4 DDX3Y SMS PRKDC DNAH8 AP3D1 TOP2B | 6.47e-05 | 1474 | 174 | 28 | int:TRIM28 |
| GeneFamily | C2 tensin-type domain containing|PTEN protein phosphatases|Phosphoinositide phosphatases | 3.96e-04 | 5 | 115 | 2 | 902 | |
| GeneFamily | Phosphoinositide phosphatases | 1.09e-03 | 32 | 115 | 3 | 1079 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 1.10e-03 | 8 | 115 | 2 | 658 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.10e-03 | 8 | 115 | 2 | 939 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.10e-03 | 8 | 115 | 2 | 837 | |
| GeneFamily | MAGE family | 2.09e-03 | 40 | 115 | 3 | 1136 | |
| GeneFamily | Fibronectin type III domain containing | 3.58e-03 | 160 | 115 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.68e-03 | 161 | 115 | 5 | 593 | |
| GeneFamily | SH2 domain containing | 3.95e-03 | 101 | 115 | 4 | 741 | |
| GeneFamily | Dyneins, axonemal | 5.12e-03 | 17 | 115 | 2 | 536 | |
| GeneFamily | Cadherin related | 5.12e-03 | 17 | 115 | 2 | 24 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 6.39e-03 | 19 | 115 | 2 | 131 | |
| GeneFamily | WD repeat domain containing | 6.61e-03 | 262 | 115 | 6 | 362 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-06 | 170 | 180 | 7 | 6210ee3bf29059e6149c047bb7e02c5f59441519 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 173 | 180 | 7 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 173 | 180 | 7 | 3e3c61468e703330788a10d850ef41a85680f86d | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-05 | 184 | 180 | 7 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-05 | 184 | 180 | 7 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 1.02e-05 | 184 | 180 | 7 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.02e-05 | 184 | 180 | 7 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.02e-05 | 184 | 180 | 7 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 187 | 180 | 7 | a2076599b33ae6750961b573bfebcb9036fa4ee8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 187 | 180 | 7 | 38ee33295a21db4aae5ba085df033db9693e41c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 187 | 180 | 7 | dbcec24d2c852964736c78e9d81650bff5c455ae | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 1.25e-05 | 190 | 180 | 7 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 1.34e-05 | 192 | 180 | 7 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-05 | 192 | 180 | 7 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.38e-05 | 193 | 180 | 7 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.38e-05 | 193 | 180 | 7 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 196 | 180 | 7 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 196 | 180 | 7 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 197 | 180 | 7 | 0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-05 | 198 | 180 | 7 | 1378c6d4ceb84b42fdd6556be3296df7a8059e6e | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-05 | 199 | 180 | 7 | 14e09eaa2335d4503de50250eb4258dd5b85b304 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 1.74e-05 | 200 | 180 | 7 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.74e-05 | 200 | 180 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-05 | 200 | 180 | 7 | 3007583eaad3a5ae2df010513d3e4df59155123d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-05 | 155 | 180 | 6 | 59035d792c26d870a8b097939e97fa47859ba68c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.72e-05 | 170 | 180 | 6 | b1a16600754e0c12f7d39c9221f1b03135833f16 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 174 | 180 | 6 | ce9bdd02dc8eb45ba9c1481619c0089b465e6442 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 176 | 180 | 6 | d687e6c3f9043f2574d072f815b8c2258f9dc7b5 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 8.14e-05 | 176 | 180 | 6 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 176 | 180 | 6 | 4f37854124d77ee64dcb40fd491eaed2ba389891 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 176 | 180 | 6 | 0afba8707b847e5bdf6f38fe4379967631fe2240 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 177 | 180 | 6 | 4a697866ed542d3201714234cee03451adf1dcc9 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5|TCGA-Skin / Sample_Type by Project: Shred V9 | 8.66e-05 | 178 | 180 | 6 | ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.21e-05 | 180 | 180 | 6 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 183 | 180 | 6 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 1.04e-04 | 184 | 180 | 6 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 1.04e-04 | 184 | 180 | 6 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 1.04e-04 | 184 | 180 | 6 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-04 | 185 | 180 | 6 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-04 | 186 | 180 | 6 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 187 | 180 | 6 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-club_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.14e-04 | 187 | 180 | 6 | a70aaae32426e9ddb1cbfbd0e0db24ccc96b9f40 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 1.14e-04 | 187 | 180 | 6 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 187 | 180 | 6 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 187 | 180 | 6 | 2c145e9d11424939dd99012a8cedf5d998b966e9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-04 | 188 | 180 | 6 | 9abd78970bbe4ed03b59a83da63bbd334712f605 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 1.17e-04 | 188 | 180 | 6 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-04 | 188 | 180 | 6 | f7dc29dfec68236883469e848be5db34f5526d6b | |
| ToppCell | P15-Epithelial-airway_epithelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.17e-04 | 188 | 180 | 6 | e3e71c0f2e374330620cb4d27638953ffa9f5298 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-04 | 188 | 180 | 6 | 5ae8ccdd328cf117da1d01ced2c3b7f763a5f1f1 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.20e-04 | 189 | 180 | 6 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.20e-04 | 189 | 180 | 6 | 26cfe5b7e7f477f225f4e9f25f983f432f01e183 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.24e-04 | 190 | 180 | 6 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.24e-04 | 190 | 180 | 6 | 15f314517ed47b12d287a12a7d18cb383310e25a | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 1.24e-04 | 190 | 180 | 6 | ec0ab31266583a0966ac7615d5c0fabb7b7e66e8 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.24e-04 | 190 | 180 | 6 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-04 | 190 | 180 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 180 | 6 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-04 | 191 | 180 | 6 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 192 | 180 | 6 | eafead22bba48ac5ee568faa8946c444445c1034 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.31e-04 | 192 | 180 | 6 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_follicular_helper_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-04 | 192 | 180 | 6 | 3e2a0f332e7f9833ba88f3c809cee78b65090401 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 192 | 180 | 6 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 192 | 180 | 6 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.32e-04 | 121 | 180 | 5 | a5962d1c476e6966870832b72d511607e047248b | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-04 | 193 | 180 | 6 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-04 | 193 | 180 | 6 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-04 | 193 | 180 | 6 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 193 | 180 | 6 | 52e918884877b6659cdca0496390e440f73694a9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 193 | 180 | 6 | 287e756d5fd3bd2931c168da24beaa0d02a350ae | |
| ToppCell | Immune_cells-small_pre-B.|Immune_cells / Lineage and Cell class | 1.39e-04 | 194 | 180 | 6 | 6a440c09805110b1e48e5959a3a9e094c6716bfb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 194 | 180 | 6 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 194 | 180 | 6 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 194 | 180 | 6 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 195 | 180 | 6 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 195 | 180 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 1.47e-04 | 196 | 180 | 6 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 196 | 180 | 6 | 65d882c6e7f6d5778b8a5fd4fdaf012e1b9f6100 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 196 | 180 | 6 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 196 | 180 | 6 | 22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 196 | 180 | 6 | 8f2031b1a9232c389517fbf3c29f47f9468b0077 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 196 | 180 | 6 | 48b4a9cea97a55190217deaf51bf867608c5a9a7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 196 | 180 | 6 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 196 | 180 | 6 | cbc727b55b6433a701b1a331028a49960fcee6ee | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 196 | 180 | 6 | 473980c827443464d08a0be28c53e3536369b12a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 196 | 180 | 6 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 196 | 180 | 6 | adee900dcd16dbaba15c58bdcace09ba20214950 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 196 | 180 | 6 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-04 | 197 | 180 | 6 | 15d1e0dffee8f5ba8cee37adfbfa0551a0cd5e15 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 198 | 180 | 6 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 198 | 180 | 6 | 451003a21162eeae90739fdb502bb50b362d80c8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.55e-04 | 198 | 180 | 6 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 198 | 180 | 6 | 953630dbe3154b1b102b87de0feca2cbf124eabe | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 198 | 180 | 6 | 440af8f90c7afa1c07000806bcf9110b70f489fb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 198 | 180 | 6 | fa84bf8533d1b91d2c2bcf06b710670605072b89 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 198 | 180 | 6 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 198 | 180 | 6 | 8e45551224fbb30c0658ad47dd98335ecf165437 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.59e-04 | 199 | 180 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 199 | 180 | 6 | 5d976d57872a8a25a11fe8cd53b01aa21a1a519a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.59e-04 | 199 | 180 | 6 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.03e-06 | 5 | 175 | 3 | C3281201 | |
| Disease | cancer (implicated_via_orthology) | 3.41e-05 | 268 | 175 | 9 | DOID:162 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 5.61e-05 | 13 | 175 | 3 | C0265338 | |
| Disease | testosterone measurement | STARD13 KAT5 CENPE NPEPPS CYP17A1 CCDC85C NR3C1 ARID1A C2CD2 FBXO38 FASN ARHGEF40 TTBK1 PTPRF SLC22A8 SKOR2 SMARCA2 MACF1 FAM47E VARS1 | 7.37e-05 | 1275 | 175 | 20 | EFO_0004908 |
| Disease | Colorectal Carcinoma | AKAP6 DPYSL2 CLSTN3 ZNF560 NTHL1 SYNE1 SPTBN2 PTEN ARID1A NCDN LIFR SH3TC1 BUB1 DNAH8 | 8.24e-05 | 702 | 175 | 14 | C0009402 |
| Disease | Vitelliform macular dystrophy | 1.05e-04 | 3 | 175 | 2 | cv:C0339510 | |
| Disease | Adult-onset foveomacular vitelliform dystrophy | 1.05e-04 | 3 | 175 | 2 | cv:C1842914 | |
| Disease | anorexia nervosa (is_implicated_in) | 1.05e-04 | 3 | 175 | 2 | DOID:8689 (is_implicated_in) | |
| Disease | Atypical juvenile parkinsonism | 1.05e-04 | 3 | 175 | 2 | C4510873 | |
| Disease | mean arterial pressure | ARHGAP42 PODXL CYP17A1 RNF213 TNS2 ITGB5 PLEKHG1 EDEM3 TTBK1 RPTOR TBX2 | 2.07e-04 | 499 | 175 | 11 | EFO_0006340 |
| Disease | Vitelliform Macular Dystrophy | 2.08e-04 | 4 | 175 | 2 | C0339510 | |
| Disease | Juvenile-Onset Vitelliform Macular Dystrophy | 2.08e-04 | 4 | 175 | 2 | C2745945 | |
| Disease | Adult-Onset Vitelliform Macular Dystrophy | 2.08e-04 | 4 | 175 | 2 | C1842914 | |
| Disease | Liver carcinoma | MAGEA3 MAGEA6 CENPE CYP4A11 CYP17A1 PTEN ARID1A LIFR FASN EGF BUB1 | 2.37e-04 | 507 | 175 | 11 | C2239176 |
| Disease | Nasopharyngeal carcinoma | 2.91e-04 | 22 | 175 | 3 | C2931822 | |
| Disease | vitelliform macular dystrophy (is_implicated_in) | 3.46e-04 | 5 | 175 | 2 | DOID:0050661 (is_implicated_in) | |
| Disease | FEV/FEC ratio | AKAP6 ARHGAP42 STARD13 TRIT1 SPEF2 U2SURP CCDC85C NASP CDH23 NR3C1 IFT43 PHF1 SCAPER KIAA0040 PLCL1 AP3D1 TOP2B CNTN2 | 3.89e-04 | 1228 | 175 | 18 | EFO_0004713 |
| Disease | X-14939 measurement | 5.16e-04 | 6 | 175 | 2 | EFO_0800747 | |
| Disease | ceramide measurement | 5.29e-04 | 235 | 175 | 7 | EFO_0010222 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 5.40e-04 | 27 | 175 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | Sezary Syndrome | 5.40e-04 | 27 | 175 | 3 | C0036920 | |
| Disease | coronary artery disease | ARHGAP42 P4HA2 INPP5D RNF213 CNPY2 ITGB5 NFU1 EPG5 PHF1 PLEKHG1 ZC3H11A RPTOR SMARCA4 KIAA0040 CCDC97 PLCL1 SEZ6L | 7.82e-04 | 1194 | 175 | 17 | EFO_0001645 |
| Disease | prostate cancer (implicated_via_orthology) | 9.82e-04 | 33 | 175 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | Malignant Neoplasms | 1.02e-03 | 128 | 175 | 5 | C0006826 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.12e-03 | 195 | 175 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | 1-ribosyl-imidazoleacetate measurement | 1.23e-03 | 9 | 175 | 2 | EFO_0800034 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.23e-03 | 9 | 175 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.46e-03 | 447 | 175 | 9 | C3714756 | |
| Disease | pulse pressure measurement | ARHGAP42 P4HA2 PODXL CYP17A1 PRPH2 RNF213 PTEN ITGB5 RGS10 PLEKHG1 FBXO38 FASN TTBK1 PIK3C2A RPTOR AP3D1 TBX2 MYBPC3 | 1.62e-03 | 1392 | 175 | 18 | EFO_0005763 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.83e-03 | 291 | 175 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | Prostatic Intraepithelial Neoplasias | 1.86e-03 | 11 | 175 | 2 | C0282612 | |
| Disease | Macrocephaly | 1.86e-03 | 11 | 175 | 2 | C0221355 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 1.86e-03 | 11 | 175 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | childhood gender nonconformity | 2.13e-03 | 43 | 175 | 3 | EFO_0020103 | |
| Disease | Bipolar Disorder | 2.27e-03 | 477 | 175 | 9 | C0005586 | |
| Disease | hypertension | 2.46e-03 | 307 | 175 | 7 | EFO_0000537 | |
| Disease | gallbladder cancer (is_implicated_in) | 2.61e-03 | 13 | 175 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | cortical thickness | AKAP6 P4HA2 STRN3 DPYSL2 SPTBN2 PLXND1 ITGB5 ITIH5 ENO4 PLEKHG1 ARHGEF40 FAR2 PTPRF GADD45G MACF1 | 2.69e-03 | 1113 | 175 | 15 | EFO_0004840 |
| Disease | eosinophil percentage of granulocytes | 2.81e-03 | 234 | 175 | 6 | EFO_0007996 | |
| Disease | parental longevity | 2.87e-03 | 494 | 175 | 9 | EFO_0007796 | |
| Disease | Adenoid Cystic Carcinoma | 3.01e-03 | 100 | 175 | 4 | C0010606 | |
| Disease | Tobacco Dependence | 3.04e-03 | 14 | 175 | 2 | C0040332 | |
| Disease | Nicotine Dependence | 3.04e-03 | 14 | 175 | 2 | C0028043 | |
| Disease | Nicotine Use Disorder | 3.04e-03 | 14 | 175 | 2 | C0376384 | |
| Disease | Disease Exacerbation | 3.10e-03 | 165 | 175 | 5 | C0235874 | |
| Disease | basophil count, eosinophil count | 3.25e-03 | 241 | 175 | 6 | EFO_0004842, EFO_0005090 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 3.35e-03 | 103 | 175 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | Retinitis Pigmentosa | 3.47e-03 | 104 | 175 | 4 | C0035334 | |
| Disease | African Burkitt's lymphoma | 3.49e-03 | 15 | 175 | 2 | C0343640 | |
| Disease | Burkitt Leukemia | 3.49e-03 | 15 | 175 | 2 | C4721444 | |
| Disease | neutrophil count | INPP5D GSDMB CDH23 CPS1 PTEN ARID1A WDR26 ZRANB3 TELO2 PRPF4 TMEM87B CLMP PLCL1 PRKDC PRORP AP3D1 PCNT | 3.64e-03 | 1382 | 175 | 17 | EFO_0004833 |
| Disease | Prostatic Neoplasms | 3.88e-03 | 616 | 175 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.88e-03 | 616 | 175 | 10 | C0376358 | |
| Disease | myopia (is_implicated_in) | 3.97e-03 | 16 | 175 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 3.98e-03 | 335 | 175 | 7 | EFO_0009931 | |
| Disease | urate measurement, bone density | 4.01e-03 | 619 | 175 | 10 | EFO_0003923, EFO_0004531 | |
| Disease | Condition, Preneoplastic | 4.24e-03 | 110 | 175 | 4 | C0282313 | |
| Disease | Precancerous Conditions | 4.24e-03 | 110 | 175 | 4 | C0032927 | |
| Disease | Moyamoya Disease | 4.49e-03 | 17 | 175 | 2 | C0026654 | |
| Disease | lupus nephritis (is_marker_for) | 4.49e-03 | 17 | 175 | 2 | DOID:0080162 (is_marker_for) | |
| Disease | spinal stenosis | 4.49e-03 | 17 | 175 | 2 | EFO_0007490 | |
| Disease | neuroimaging measurement | STRN3 DPYSL2 DPYSL3 PODXL PLXND1 ITGB5 ITIH5 ENO4 PLEKHG1 GADD45G SYNJ1 SMARCA2 MACF1 PLCL1 | 4.77e-03 | 1069 | 175 | 14 | EFO_0004346 |
| Disease | migraine disorder, systolic blood pressure | 5.03e-03 | 18 | 175 | 2 | EFO_0006335, MONDO_0005277 | |
| Disease | Carcinoma, Granular Cell | 5.11e-03 | 116 | 175 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 5.11e-03 | 116 | 175 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 5.11e-03 | 116 | 175 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 5.11e-03 | 116 | 175 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 5.11e-03 | 116 | 175 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 5.11e-03 | 116 | 175 | 4 | C0001418 | |
| Disease | eosinophil percentage of leukocytes | INPP5D SPEF2 GSDMB NR3C1 CPS1 PTEN IL18RAP PRKDC MUC2 TET3 CRBN | 5.12e-03 | 746 | 175 | 11 | EFO_0007991 |
| Disease | Chronic myeloproliferative disorder | 5.60e-03 | 19 | 175 | 2 | C1292778 | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 5.60e-03 | 19 | 175 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | response to methotrexate, neurotoxicity | 5.60e-03 | 19 | 175 | 2 | EFO_0011057, GO_0031427 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 5.60e-03 | 19 | 175 | 2 | DOID:4928 (is_marker_for) | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 5.93e-03 | 121 | 175 | 4 | EFO_0008595, EFO_0020943 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDPETSWILLNEDDL | 561 | Q9HCE0 | |
| QPVADDTCLEKLLDW | 21 | Q6PJG6 | |
| EAWDLDVKQISLAPE | 1451 | Q8TER5 | |
| KDPDLFWDDSALTII | 891 | Q9BQT9 | |
| PDISDDKDEWQSLDQ | 481 | O43683 | |
| LDEDTSLPEGLKDWN | 766 | Q9Y4W6 | |
| RSWLEEFLKPSDNEE | 16 | Q8N888 | |
| RPVSFSDWEKLDAEE | 451 | P22570 | |
| WEKFVSPETLESILE | 281 | Q9NZJ6 | |
| DSDLVIWDPDAVKIV | 406 | Q14195 | |
| ILDTDGDKWLDELDS | 61 | Q8TAX9 | |
| AILWETELEKEDDPL | 701 | Q9UK96 | |
| LREWDENLKDDSLPS | 261 | Q96SW2 | |
| DKWEELLGQDSPLEV | 171 | Q02928 | |
| LLPQGEDVEKVLDEW | 76 | Q8IU60 | |
| TQEDGLDDPRLEKLW | 141 | P30533 | |
| DLPENLSEIADLWNS | 3151 | Q9H251 | |
| SSILLDVKPWDDETD | 196 | P29692 | |
| LDLDAWINEPLSDSE | 621 | O14617 | |
| WLADALKENDPSSVL | 146 | Q9BZG1 | |
| AKWAASLENLLEDPE | 36 | O43665 | |
| SDSEAQKIRELAEPW | 356 | Q7Z4N8 | |
| SKDETPLCTLLDWQD | 1961 | O14497 | |
| LIIFWDIKEEVDPSD | 76 | Q9P2P5 | |
| LEWLDDAIIDEITPK | 181 | Q96K12 | |
| DSWIVPLDNLTKDDL | 536 | O00592 | |
| DVSKWEESVLEPALE | 351 | Q9H3H1 | |
| IKDSDLEWEVSVPEA | 291 | O95256 | |
| LNEWTEDDELPEATV | 591 | Q9H511 | |
| PNDKEEIDTSRLFEW | 1436 | Q9NU22 | |
| APEEKIWEELSVLEV | 216 | P43357 | |
| APEEKIWEELSVLEV | 216 | P43360 | |
| APEEKIWEELSVLEA | 216 | P43365 | |
| PDFITVTKENEELDW | 116 | Q9UMS0 | |
| VTKENEELDWNLLKP | 121 | Q9UMS0 | |
| AETQCWKEAEPDLLA | 206 | Q9UBB6 | |
| LSSWLQSDDEPEKER | 586 | Q86UX2 | |
| VDTSEEALLLPDWLK | 1206 | Q8N201 | |
| EPFEETEEKWLSSLE | 356 | Q9NXD2 | |
| DADLVIWDPDSVKTI | 406 | Q16555 | |
| IWNGKSDLLADPEDV | 306 | Q5W064 | |
| ALWELKLDPDSVDEI | 156 | Q9BY71 | |
| SPDWKNLLIDVTRED | 86 | A2RU37 | |
| DWLEKESEQEPLVRA | 796 | Q76MJ5 | |
| DEEDLWISAQPKLLQ | 76 | Q15053 | |
| KVQPIDSILADWNED | 906 | Q9BZQ6 | |
| DNEDEWPLAEILSVK | 21 | Q92993 | |
| SQVPDEELLRWSKEE | 16 | A6NKD9 | |
| KDSEAWVPDSEERLI | 266 | Q96F63 | |
| DDIIDKLPEIWETLF | 1196 | Q5VYK3 | |
| AEWDQIEPLLRSELE | 86 | Q9NVH0 | |
| KLWTLVSDPDTDALI | 21 | Q00613 | |
| LSEEWLLRENIEAKP | 1541 | Q9Y4D7 | |
| KSEDISKFDWLDLDP | 261 | O00443 | |
| SSLLAKDPWDAVLLE | 296 | O00443 | |
| KDPWDAVLLEERSTA | 301 | O00443 | |
| KLDWLDDPCSLNIES | 566 | Q02817 | |
| LEPEEKAEDCWELQI | 566 | Q14807 | |
| KAEDCWELQISPELL | 571 | Q14807 | |
| DPDLEKSTEALRWDL | 1471 | Q92817 | |
| EPVILNLEKTWEESD | 3891 | Q96JB1 | |
| NLEKTWEESDTRTPL | 3896 | Q96JB1 | |
| PLLEVDLDSFEDKPW | 151 | Q6UN15 | |
| LEWKLSLQELPEDRS | 86 | Q8TB73 | |
| KETNESPWRSDLLID | 206 | P04150 | |
| ENLEKWLEVDSTEPG | 426 | Q9Y4A0 | |
| AQLKEVWEELDGLDP | 226 | Q02818 | |
| ISDDIDDPKWTLCLQ | 41 | Q9P2X3 | |
| KVELSVWDQPEDLNL | 381 | P18084 | |
| LEETWSDVALPELDR | 1206 | O95613 | |
| SAEEPQEKVDLTLDW | 191 | P49321 | |
| DALEPLLSWLADTEE | 5351 | Q9UPN3 | |
| QLLIAPFKEEDEWDS | 321 | O15460 | |
| VSKSSWLEEDDDPVV | 381 | O15460 | |
| DDEEDSLELQEVWIP | 601 | Q6PIJ6 | |
| DLKAREAEAWEEPTE | 321 | Q8NC74 | |
| EELWKENPSATLEDL | 266 | Q92900 | |
| PLEGEELQRKLAWED | 136 | Q9BYG0 | |
| EKPNSIEELAELREW | 856 | Q9P2D7 | |
| KEWPSNLDLRKELSE | 831 | P31327 | |
| EVLTEWDPLQTEKED | 186 | Q96FT9 | |
| APKPQEDELDSWDLE | 571 | Q9Y426 | |
| EDELDSWDLEKEPQA | 576 | Q9Y426 | |
| EWLESVKENPAVIDF | 471 | P13671 | |
| AEDDTWEPEQKLCKL | 306 | P01133 | |
| EADDQQLLEPEAWKT | 26 | Q9BVV2 | |
| NEDAWKDPALEKLSL | 126 | O95257 | |
| QKLLPWEPSLESEEE | 11 | Q6P531 | |
| WETLDPSVLEDPNLK | 331 | Q8NBF6 | |
| DLPSAEELEDWLEDV | 366 | P31415 | |
| IDNLSKDSLVDLVPW | 206 | P05093 | |
| DKWEELLGQDSPLEV | 171 | Q5TCH4 | |
| DELEWEIAQVDPKKT | 36 | Q9Y2B0 | |
| VEQWDSDEPIPAKEL | 31 | Q9UBQ7 | |
| ELCDLEETPVSWKDD | 336 | Q4V339 | |
| QPEWLKVISDTEADI | 326 | Q02246 | |
| IDPFRKEDSEQWDSI | 441 | A6NNW6 | |
| LDKLEADRSWENIPV | 231 | Q8IYD9 | |
| DLLVEAKQEVPSWLE | 556 | O15523 | |
| ILADEDSSRPVWLKA | 1431 | P49327 | |
| PETIEDLENWSLRAK | 501 | Q8TCC7 | |
| RNLIAWSVPLESKDD | 26 | Q9BY12 | |
| EDLWESLENASGKPI | 476 | P55786 | |
| LDTLSEIEWNPATKL | 476 | Q02224 | |
| DWLSQKDEELSAQLP | 116 | Q13474 | |
| SADSILVKWEDIPVE | 736 | P42702 | |
| LEPEWAAAASEVKEQ | 196 | Q15084 | |
| WSTPEELELDELLEA | 1151 | P10586 | |
| IKPFCEDLDQWLSED | 101 | P60484 | |
| EDDSQFLVLWKDISP | 66 | O43189 | |
| IDDSEITKEDDALWP | 66 | Q96A72 | |
| ECSWKDPEAEAALEL | 1096 | P26640 | |
| LEVLDPDRKLEDTWA | 146 | Q6ZV65 | |
| PEEDSTWEFLRLILD | 286 | P52788 | |
| LPDDLWDDEETKAEL | 1091 | Q9C093 | |
| KDDLSPTAEVWDVDQ | 331 | Q13033 | |
| LQEVVDDWSKDVLPE | 496 | Q9Y3M8 | |
| SEEASEVPLWLDRKE | 176 | Q9BYH1 | |
| LSEEEEETPSRDWIK | 941 | Q7Z5M5 | |
| TEDPLLSWADFTKRE | 531 | P52630 | |
| LLEEAKDLLSDWLDS | 186 | P49589 | |
| EEDELPSWIIKDDAE | 1276 | P51531 | |
| LDLLTQIDLEDNPWD | 506 | Q9H5Y7 | |
| PSDLWKEDLAAFVEE | 1181 | Q02880 | |
| SIEEEDNPIWSLIDK | 426 | Q8N4U5 | |
| KDFEVSAEPIQDWLS | 3176 | Q8NF91 | |
| PTQDDLKWSLVSLDE | 266 | Q14DG7 | |
| IALKSPDWIKNLEEE | 966 | O43426 | |
| KSPPDIDIDIELWDN | 436 | A6NI28 | |
| KLWSLDSDEPVADIE | 306 | O43172 | |
| PAEIDSLWEISKQIE | 406 | P49821 | |
| TKSPEETRAALEEWL | 256 | P78549 | |
| WEQLKDDSLALDPLV | 546 | O15353 | |
| EKLEWAVDEEDTARP | 736 | Q8NDX1 | |
| DELPSWIIKDDAEVE | 1341 | P51532 | |
| KPKWDLDDEILQLET | 246 | Q8WXH5 | |
| TQEDPLSEKEWLEIL | 451 | Q92835 | |
| EARSWLADVAEKDPD | 796 | Q9Y4R8 | |
| DDWEDPEALSSLLLF | 491 | Q8TE82 | |
| LISKDWPELQDDIPS | 226 | Q8WX94 | |
| VLTDLDSKQLEWPSE | 61 | B1ATL7 | |
| SLWTDPTEDDEKLIE | 731 | Q9NWF9 | |
| EPLSKPWLEDDDSLL | 626 | Q9BZV3 | |
| DIWALQKDVEDFLSP | 116 | Q13405 | |
| LDWEDSLPDRDLALA | 186 | Q8N6T7 | |
| TQPLNSEEWDKLKED | 116 | O15091 | |
| EDEADLTDWNLPLAF | 16 | Q8N122 | |
| VAPSKWEAVDESELE | 756 | O15042 | |
| SEDEDSPLDALDLVW | 1076 | P55201 | |
| PNDLLEKVDSINEKW | 1031 | Q13023 | |
| LPEKDTLDIEWLLTD | 41 | Q9H6B4 | |
| LLSRDWPESSEKIED | 201 | Q7RTR0 | |
| NWEKEIAAVISPELE | 4676 | Q63HN8 | |
| TLDTDLQALRWEPSK | 136 | Q15111 | |
| NKVPLEDTETDELWA | 336 | Q6RFH5 | |
| PLAEEEDFDSKEWVI | 531 | Q5TCY1 | |
| LWESKLDAKPELQDL | 66 | Q12768 | |
| AEEETEEKPSVWLCL | 61 | Q9Y5T5 | |
| KDSLNEAWADLLELL | 1776 | O15020 | |
| VEDDPKVTLEAKELW | 101 | Q13207 | |
| PEESESESEGWLLEK | 296 | P23942 | |
| EPLEEETEDVANLWN | 4436 | Q15413 | |
| SSKEWIIDLPQNEDI | 521 | O75717 | |
| WDLEESQPEAKKARL | 36 | Q96IC2 | |
| DDTKEWLIEVPGNAD | 151 | Q15050 | |
| PLSVEDDFEKLIWEI | 766 | O75152 | |
| LLWGPLEEESASKEK | 86 | Q9H9D4 | |
| SAWKLVLLGADEEEP | 126 | Q9BU02 | |
| LEDALLPETLIKWDS | 266 | Q6UXR4 | |
| LEELEEWGNPSSDEK | 601 | Q4J6C6 | |
| LKSEEKLWDPFSLEE | 1596 | O43151 | |
| TDKSPQDELVFAWED | 216 | Q2VWA4 | |
| PTEAEKDFWELASLD | 2986 | P78527 | |
| DLKWVEENIPSSFTD | 511 | Q96K49 | |
| PEDKWTIDDIAQSLE | 291 | Q8WWH5 | |
| TWADETKEVITDNLP | 361 | Q9H598 | |
| PVSDKLSEEVDEIWN | 826 | Q9ULL1 | |
| DIWKCEKDSLPIDLS | 941 | Q9Y4F4 | |
| DWDKAENDLNELKPL | 171 | Q9H7D7 | |
| VSEPEASAAEWKQLD | 36 | Q9Y6Q3 | |
| NEEWELLDPTPKDLE | 251 | Q9UPU7 | |
| DVAVDFTEKEWPLLD | 61 | Q96PQ6 | |
| LTFPKDQLDEAWTDE | 396 | Q63HR2 | |
| LLEVWKDNRTDDIPE | 296 | Q8NFA0 | |
| LFKPSVISWLEEEEL | 56 | Q96MR9 | |
| WTPNDSSEELRKEAL | 496 | Q5FWF4 | |
| LSPKWFIDEDEISQE | 96 | Q8NB42 | |
| DLPAEDWIVANKDLI | 776 | Q00872 | |
| SKLEAPAEEDVWEIL | 311 | Q14896 |